Atopic Dermatitis Journal Articles

• Dupilumab in Mild to Moderate Asthma Comorbid With CRSwNP Is dupilumab an effective treatment option for asthma patients with chronic sinusitis with nasal polyps? A new study examines the real-life effects.
  BMC Pulmonary Medicine, August 12, 2022
• Efficacy and Safety of Arylia vs Prolia in Osteoporosis Is this newly developed denosumab biosimilar as safe and effective as the reference product in the treatment of osteoporosis?
  Arthritis Research & Therapy, August 09, 2022
• Antimicrobial Resistance and Dermatological Ramifications Dermatologist are among the most common prescribers of antibiotics, often for prolonged courses. Review strategies to combat antimicrobial resistance as it pertains to dermatology in this paper.
  The British Journal of Dermatology, July 25, 2022
• Targeting IL-1 Family Cytokines in Inflammatory Skin Diseases This review elucidates the role of the different IL-1 cytokines in inflammatory skin disorders. What progress is being made in developing targeted treatments to inhibit their effects?
  The British Journal of Dermatology, July 18, 2022
• A Systemic Review of Therapeutic Options for Peanut Allergy This review provides an update on recent diagnostic and treatment advances in the setting of peanut allergy.
  Current Opinion in Allergy and Clinical Immunology, July 05, 2022
• Rapid Healing and Preventing Recurrence of Venous Ulcers Learn more about a treatment strategy for the management of venous ulcers that may shorten healing time and help prevent recurrence.
  Wounds, June 13, 2022
• Risk of Herpesvirus and Serious Infections in Atopic Dermatitis This study suggests that atopic dermatitis is associated with an increased risk of hospital admission with infections, opportunistic infections and herpesvirus infections in both children and adults.
  The British Journal of Dermatology, May 10, 2022
• Long-term Safety of Risankizumab in Plaque Psoriasis The safety findings in this analysis support risankizumab as a long-term treatment option for patients with moderate-to-severe psoriasis.
  The British Journal of Dermatology, April 18, 2022
• Tralokinumab Plus Topical Corticosteroids in Severe AD This study evaluated the efficacy and safety of tralokinumab plus topical corticosteroids in adult patients with severe AD whose disease was not adequately controlled with ciclosporin A.
  The British Journal of Dermatology, April 11, 2022
• Conjunctivitis in Moderate-to-severe Atopic Dermatitis Are patients receiving tralokinumab for moderate-to-severe atopic dermatitis at increased risk of developing conjunctivitis?
  The British Journal of Dermatology, April 04, 2022
• Predictive Diagnostic Criteria for Psoriasis in Children The clinical presentation of psoriasis often differs in children compared with adults. This paper proposes seven criteria for accurate diagnosis of psoriasis in children and young people.
  The British Journal of Dermatology, March 21, 2022
• Janus Kinase and Tyrosine Kinase Inhibitors in Dermatology This review details the mechanism of action of JAK inhibitors and assesses their efficacy and safety in the treatment of a wide variety of dermatological conditions.
  Skin Therapy Letter, March 17, 2022
• The Epidemiology of Alopecia Areata This study elucidates the epidemiology of alopecia areata, focusing on incidence, demographics and patterns of healthcare utilization.
  The British Journal of Dermatology, March 14, 2022
• Association Between Atopic Dermatitis and Hypertension This meta-analysis investigated whether persons with atopic dermatitis are at increased risk for hypertenstion.
  The British Journal of Dermatology, March 07, 2022
• Cutaneous Reactions After SARS-CoV-2 Vaccination This study described and classified cutaneous reactions reported after vaccination with both mRNA and AstraZeneca SARS-CoV-2 vaccines.
  The British Journal of Dermatology, February 14, 2022
• Roles of Environmental Exposures in Adult Allergic Disorders Recent findings help further our understanding of the impacts of environmental exposures on the development of allergic disorders in adults.
  Current Opinion in Allergy and Clinical Immunology, January 10, 2022
• Management of Skin Conditions Caused by PPE and Handwashing Prolonged usage of personal protective equipment and frequent handwashing due to the COVID-19 pandemic has exacerbated or caused skin conditions. Can moisturizers and cleansers help?
  Skin Therapy Letter, October 22, 2021
• Association Between Atopic Dermatitis and Autoimmune Diseases This large population-based study explored the association between atopic dermatitis and a wide spectrum of autoimmune diseases. Which autoimmune disorders had the strongest association?
  The British Journal of Dermatology, September 15, 2021
• Prurigo Nodularis: Review and Emerging Treatments Review current understanding of the pathogenesis of prurigo nodularis, a chronic, inflammatory skin condition characterized by the presence of pruritic nodules. What therapeutics show promise?
  Skin Therapy Letter, August 18, 2021
• Atopic Dermatitis and Psychiatric Disorders in Childhood Other than ADHD, which is known to be associated with atopic dermatitis in children, are there other psychiatric conditions or treatments associated with childhood AD?
  The British Journal of Dermatology, August 05, 2021